Biodexa Pharmaceuticals Plc (BDRX)
0.775
-0.01
(-0.74%)
USD |
NASDAQ |
Sep 02, 16:00
0.7604
-0.01
(-1.88%)
After-Hours: 20:00
Biodexa Pharmaceuticals Research and Development Expense (TTM) : 5.234M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | 5.234M |
| June 30, 2025 | 6.352M |
| December 31, 2024 | 6.961M |
| June 30, 2024 | 5.044M |
| December 31, 2023 | 5.051M |
| June 30, 2023 | 5.944M |
| December 31, 2022 | 6.296M |
| June 30, 2022 | 6.731M |
| December 31, 2021 | 6.394M |
| June 30, 2021 | 5.506M |
| December 31, 2020 | 7.738M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.54M |
| December 31, 2019 | 9.994M |
| June 30, 2019 | 10.64M |
| December 31, 2018 | 12.49M |
| June 30, 2018 | 11.79M |
| December 31, 2017 | 10.73M |
| June 30, 2017 | 11.16M |
| December 31, 2016 | 8.809M |
| June 30, 2016 | 9.144M |
| December 31, 2015 | 9.024M |
| June 30, 2015 | 4.897M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NuCana Plc | 12.59M |
| Mereo BioPharma Group Plc | 14.98M |
| BioNTech SE | 2.414B |
| Silence Therapeutics Plc | 43.54M |
| Autolus Therapeutics Plc | 112.42M |